Are prospectively collected samples or remnant samples exempt from Research Ethics Board approval?
If prospectively collected specimens obtained for clinical or diagnostic purposes are to be used for research purposes, then the specimens used in future protocols must be approved by a Research Ethics Board before the specimens are used. Biological wastes and left-over specimens are included in this category. None of these studies will qualify for exempt status, but will require either expedited or full board review. Depending on the nature of the research, the Member Tumour Bank may be required to obtain informed consent from the patients for the new use.
Related Questions
- From a hospital research governance and ethics point of view, could research samples be collected at the same time as patients other routine bloods are being taken?
- Under the Research Ethics approval system, what is a research domain and how does it affect my application?
- Are all samples collected under the required IRB/ethics approval with informed consent?
